Overview
Martin Doerfler serves as Chief Medical Officer at Bayesian Health[1][2]. Doerfler holds a Doctor of Medicine from the University of Pittsburgh School of Medicine[10] and a Bachelor of Science in Chemistry from the University of Pittsburgh[11]. Prior roles include Senior Vice President for Clinical Strategy and Development at Northwell Health[9], Professor of Medicine and Science Education at the Donald and Barbara Tucker School of Medicine at Hofstra/Northwell[8], and Executive Vice President of Healthcare at Truveta[6]. Doerfler also serves as a Board Member of END SEPSIS, the Legacy of Rory Staunton[5], and as an Advisor to both Bayesian Health[3] and Qualified Health PBC[4].
Career history
- Chief Medical OfficerJul 2026 to presentBayesian Health
- AdvisorNov 2025 to presentBayesian Health
- AdvisorFeb 2024 to presentQualified Health PBC
- Board MemberJan 2017 to presentEND SEPSIS, the Legacy of Rory Staunton
- Executive Vice President, HealthcareApr 2023 to May 2024Truveta
- Founding Board MemberOct 2020 to May 2023Truveta
- Professor of Medicine and Science EducationJan 2017 to Dec 2023The Donald and Barbara Tucker School of Medicine at Hofstra / Northwell
- SVP for Clinical Strategy and DevelopmentMar 2013 to Nov 2023Northwell Health
Education
- Doctor of Medicine (MD), Medicine1978 - 1982University of Pittsburgh School of Medicine
Bachelor of Science (BS), Chemistry1974 - 1978University of Pittsburgh
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.